Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.

[1]  Adnan Al Shaikh,et al.  Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center , 2020, Acta bio-medica : Atenei Parmensis.

[2]  C. Tinelli,et al.  Efficacy of long-term growth hormone therapy in short non-growth hormone-deficient children , 2017, Journal of pediatric endocrinology & metabolism : JPEM.

[3]  C. Polychronakos,et al.  Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency , 2016, Hormone Research in Paediatrics.

[4]  C. Ruivenkamp,et al.  MECHANISMS IN ENDOCRINOLOGY: Novel genetic causes of short stature. , 2016, European journal of endocrinology.

[5]  D. Dunger,et al.  GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults , 2015, European journal of endocrinology.

[6]  E. Yang,et al.  Comparison of Growth Hormone Treatment in Patients with Idiopathic Short Stature and Idiopathic Growth Hormone Deficiency , 2014, Chonnam medical journal.

[7]  Yan Liang,et al.  [Attach great importance to the standardized clinical usage and safety monitoring of recombinant human growth hormone in children]. , 2013, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[8]  E. Monti,et al.  The SHOX gene and the short stature. Roundtable on diagnosis and treatment of short stature due to SHOX haploinsufficiency: how genetics, radiology and anthropometry can help the pediatrician in the diagnostic process Padova (April 20th, 2011). , 2012, Pediatric endocrinology reviews : PER.

[9]  J. Dahlgren.  Metabolic Benefits of Growth Hormone Therapy in Idiopathic Short Stature , 2011, Hormone Research in Paediatrics.

[10]  M. Zwahlen,et al.  Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. , 2011, The Journal of clinical endocrinology and metabolism.

[11]  C. Meazza,et al.  Efficacy of long-term growth hormone therapy in short children with reduced growth hormone biological activity , 2011 .

[12]  H. Bauchner,et al.  Variation in Methods of Predicting Adult Height for Children With Idiopathic Short Stature , 2010, Pediatrics.

[13]  J. Salles,et al.  Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment. , 2010, Journal of Clinical Endocrinology and Metabolism.

[14]  P. Cohen,et al.  Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children. , 2010, The Journal of clinical endocrinology and metabolism.

[15]  J. Åman,et al.  Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency. , 2008, The Journal of clinical endocrinology and metabolism.

[16]  P. Cohen,et al.  Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. , 2008, The Journal of clinical endocrinology and metabolism.

[17]  C. Tinelli,et al.  Response to Long-Term Growth Hormone Therapy in Short Children with Reduced GH Bioactivity , 2006, Hormone Research in Paediatrics.

[18]  M. Ranke,et al.  Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. , 2006, The Journal of clinical endocrinology and metabolism.

[19]  Brenda J. Crowe,et al.  Safety of growth hormone treatment in pediatric patients with idiopathic short stature. , 2005, The Journal of clinical endocrinology and metabolism.

[20]  Brenda J. Crowe,et al.  Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. , 2004, The Journal of clinical endocrinology and metabolism.

[21]  M. M. Ilondo,et al.  Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society , 2000 .

[22]  K. Furusho,et al.  Unfavorable effects of growth hormone therapy on the final height of boys with short stature not caused by growth hormone deficiency. , 1997, The Journal of pediatrics.

[23]  J. Wit,et al.  Spontaneous Growth and Response to Growth Hormone Treatment in Children with Growth Hormone Deficiency and Idiopathic Short Stature , 1996, Pediatric Research.

[24]  H. Delemarre-van de Waal,et al.  Long‐term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues , 1995 .

[25]  F. Roelfsema,et al.  Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy. , 2013, The Journal of clinical endocrinology and metabolism.

[26]  L. Levitsky,et al.  Predictors and Growth Consequences of Central Hypothyroidism in Pediatric Patients Receiving Recombinant Human Growth Hormone , 2010, Journal of pediatric endocrinology & metabolism : JPEM.

[27]  K. Parker,et al.  Long-term safety of recombinant human growth hormone in children. , 2010, The Journal of clinical endocrinology and metabolism.